What Does Full Approval of Pfizer’s COVID-19 Vaccine Mean?
On Aug. 23, the FDA gave full approval to the Pfizer/BioNTech COVID-19 vaccine for people 16 and older. Since last December, nearly 202 million Americans have received at least one dose of a vaccine, including the two-dose vaccines made by Pfizer/BioNTech and Moderna, and Johnson & Johnson’s single-dose vaccine. In recent months, the pace of vaccinations has slowed even as the delta variant is causing a new wave of cases, hospitalizations and deaths. But the FDA’s endorsement of the Pfizer/BioNTech vaccine may convince more unvaccinated people to get their shot and clear the way for more employers to impose vaccine mandates. A recent poll from the Kaiser Family Foundation found that 31% of unvaccinated people would be more likely to get their shots if the vaccine gets full approval.
Related Posts
Meet Our Reporters
-
Lauren Flynn Kelly Executive Editor, AIS Health, and Managing Editor, Radar on Medicare Advantage
View Lauren Flynn Kelly's Profile -
Angela Maas Managing Editor, Radar on Specialty Pharmacy and Spotlight on Market Access
View Angela Maas's Profile -
Leslie Small Managing Editor, Health Plan Weekly and Radar on Drug Benefits
View Leslie Small's Profile -
Peter Johnson Reporter, Health Plan Weekly and Radar on Drug Benefits
View Peter Johnson's Profile -
Tim Casey Reporter, Health Plan Weekly and Radar on Drug Benefits
View Tim Casey's Profile -
Carina Belles Reporter, Radar on Medicare Advantage and Spotlight on Market Access
View Carina Belles's Profile -
Jinghong Chen Reporter, Health Plan Weekly and Radar on Drug Benefits
View Jinghong Chen's Profile